In alignment with the rapidly changing society,
the medical paradigm is also undergoing rapid changes towards prevention of illness,
healthcare and customized medical treatments, transcending the realm of simple treatment.

GENINUS Inc. succeeded in the commercialization of the clinical sequencing platform
for analysis of cancer genes and screening of customized anticancer drug for the
first time in Korea in our 2nd year of operation.
As such, we are putting in our utmost efforts to provide the best services that are helpful
to both clinicians and patients in alignment with the rapidly changing medical paradigm.

GENINUS Inc. has high level of understanding on the diseases and patients on the foundation
of the highly experienced and skilled manpower at the SGI of SMC and advanced technologies.
We are continuing with our R&D cooperation in order to ensure that a wide range of
technologies are actually helpful to the patients and general public.
As such, we shall provide more convenient and accurate services than any other company
through continuous R&D.

GENINUS Inc. is grafting Big Data on the genome of Koreans onto the healthcare services.
We will be utilizing genome big data to create healthier future for all of us.
We will create a world in which your DNA makes you, your family and friends healthier.